These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Punding Under Methylphenidate Treatment in a Patient With Adult Attention-Deficit/Hyperactivity Disorder. Aydin Ö; Tanriöver E; Poyraz CA J Clin Psychopharmacol; 2020; 40(6):631-632. PubMed ID: 33136926 [No Abstract] [Full Text] [Related]
4. Methylphenidate-Induced Raynaud Phenomenon Developed After Increasing Methylphenidate in an Adult With Attention-Deficit Hyperactivity Disorder. Monteerarat Y; Pariwatcharakul P J Clin Psychopharmacol; 2019; 39(2):178-179. PubMed ID: 30811376 [No Abstract] [Full Text] [Related]
5. Excessive and Frequent Menstrual Bleeding With Methylphenidate in an Adolescent Girl With Attention-Deficit Hyperactivity Disorder. Coskun M; Adak I J Clin Psychopharmacol; 2017 Oct; 37(5):637-639. PubMed ID: 28719424 [No Abstract] [Full Text] [Related]
6. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder? Killeen MR J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478 [No Abstract] [Full Text] [Related]
7. Methylphenidate for attention-deficit/hyperactivity disorder: The longest debate. Levy F Aust N Z J Psychiatry; 2016 Jul; 50(7):616-7. PubMed ID: 27066820 [No Abstract] [Full Text] [Related]
8. [Methylphenidate. A drug for attention deficit disorders to be used with precaution]. Taéron C Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855 [No Abstract] [Full Text] [Related]
9. Increase in Menstrual Cycle Length Induced by Extended-Release Methylphenidate in an Adolescent with Attention-Deficit/Hyperactivity Disorder. Mutlu C; Bahalı K; Gunes H; Adaletli H J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):860-861. PubMed ID: 26397126 [No Abstract] [Full Text] [Related]
10. Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed? Hoekstra PJ; Buitelaar JK Eur Child Adolesc Psychiatry; 2016 Apr; 25(4):339-40. PubMed ID: 27021055 [No Abstract] [Full Text] [Related]
11. Methylphenidate associated vitiligo in a child: A case report. Guler Aksu G; Akdere P; Toros F Asia Pac Psychiatry; 2019 Sep; 11(3):e12351. PubMed ID: 30821429 [No Abstract] [Full Text] [Related]
12. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature. Kraemer M; Uekermann J; Wiltfang J; Kis B Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380 [TBL] [Abstract][Full Text] [Related]
13. Stuttering Associated With the Use of Short-Acting Oral Methylphenidate. Alpaslan AH; Coşkun KŞ; Kocak U; Gorücü Y J Clin Psychopharmacol; 2015 Dec; 35(6):739-41. PubMed ID: 26436866 [No Abstract] [Full Text] [Related]
14. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. Pae CU Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730 [No Abstract] [Full Text] [Related]
16. Is There an Effect of Methylphenidate on Thrombocytopenia? Ercan ES; Inci SB; Ipci M J Clin Psychopharmacol; 2017 Jun; 37(3):374. PubMed ID: 28301399 [No Abstract] [Full Text] [Related]
17. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)]. Golubchik P; Sever J; Weizman A Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124 [TBL] [Abstract][Full Text] [Related]
18. Trichotillomania in Attention-Deficit/Hyperactivity Disorder Under Methylphenidate Treatment. Kara T; Akaltun İ J Clin Psychopharmacol; 2017 Aug; 37(4):484. PubMed ID: 28492426 [No Abstract] [Full Text] [Related]
19. Methylphenidate euphoria. Corrigall R; Ford T J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421. PubMed ID: 8936903 [No Abstract] [Full Text] [Related]